Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
CAS Number:
NACRES:
NA.22
UNSPSC Code:
12352204
EC Number:
232-668-6
MDL number:
Specific activity:
≥150 U/mg
Product Name
Lactoperoxidase from bovine milk, lyophilized, powder, ≥150 U/mg
SMILES string
[O+H2]O[O-]
InChI key
JSPLKZUTYZBBKA-UHFFFAOYSA-N
InChI
1S/H2O3/c1-3-2/h1-2H
form
powder
quality
lyophilized
specific activity
≥150 U/mg
mol wt
Mr ~77500
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
Quality Level
Gene Information
cow ... LPO(280844)
Looking for similar products? Visit Product Comparison Guide
Biochem/physiol Actions
Lactoperoxidase catalyzes the oxidation of iodide to iodine by hydrogen peroxide. This activity provides a gentle, specific alternative to chloramine T for the radioiodination of proteins and DNA.
Other Notes
1 U corresponds to the amount of enzyme which oxidizes 1 μmol ABTS (Cat. No. 11557) per minute at pH 6.0 and 25°C
Lactoperoxidase system of bovine milk, review; Structural and functional properties of; Products of lactoperoxidase-catalyzed oxidation of thiocyanate and halides
Sales restrictions may apply
signalword
Danger
hcodes
pcodes
Hazard Classifications
Resp. Sens. 1
Storage Class
11 - Combustible Solids
wgk
WGK 1
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
低风险生物材料
动植物源性产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
E.L. Thomas
Immunology Series, 27, 31-31 (1985)
P.I Ohlsson et al.
Protides Biol. Fluid Proc. Colloq., 32, 125-125 (1984)
B. Reiter
Immunology Series, 27, 123-123 (1985)
Mohanned Naif Alhussien et al.
Scientific reports, 10(1), 11161-11161 (2020-07-09)
Detection of subclinical mastitis (SCM) in its initial stage can save great economic losses, improve milk quality and animal welfare. We have developed a semiquantitative lateral flow assay for the detection of SCM in dairy cows targeting myeloperoxidase (MPO) enzyme
Marie Thérèse Droy-Lefaix et al.
Investigative ophthalmology & visual science, 54(4), 2705-2710 (2013-03-23)
The aim of this study was to evaluate the interest of an ophthalmic eyedrop preparation containing a myosin light chain kinase (MLCK) inhibitor, ML-7, in the treatment of ocular surface. The local protective effect on the inflammation and the increase
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service